Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ACDF Using Structural Allograft vs. Tritanium C

NCT: NCT04388332 · RECRUITING

NCT IDNCT04388332
StatusRECRUITING
Start Date2020-08-20
Completion2026-12
SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (OTHER)
First posted
Last updated

Brief Summary

This is an observational, descriptive, prospective and retrospective data collection study. The purpose of this study is to observe radiographic outcomes of patients who will undergo anterior cervical discectomy and fusion (ACDF) utilizing Tritanium C (Stryker Spine). The rate of fusion success and adverse events will be compared retrospectively to patients who underwent instrumented ACDF utilizing structural allograft bone with plates.

Frequently Asked Questions

What is ACDF Using Structural Allograft vs. Tritanium C?

ACDF Using Structural Allograft vs. Tritanium C is a clinical trial registered under NCT04388332. Current status: RECRUITING.

What is the status of NCT04388332?

The current status of NCT04388332 (ACDF Using Structural Allograft vs. Tritanium C) is: RECRUITING.

When did ACDF Using Structural Allograft vs. Tritanium C start?

ACDF Using Structural Allograft vs. Tritanium C started on 2020-08-20.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.